Superior insight in drug safety and efficacy

Washington  •  London  •  Paris

• Drug safety
  • Patient profiles at risk of adverse events
• Clinical development
  • Target population for efficacy
  • Composite endpoint optimization
  • Fraud detection

Key applications - Clinical development

Composite endpoint optimization

In some specific therapeutic area for which efficacy assessment remains based on subjective endpoints and patient reported outcomes, high level of placebo effect interferes with the assessment of the real efficacy of an active drug.

Finding optimal composite endpoints which minimize this placebo effect allows a better assessment of the real efficcy of a new drug.